Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Operating Activities:
Net loss	$ (33,479,378)	$ (35,238,648)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,180,529	4,244,349
Share based compensation	708,776	689,911
Amortization of financing costs to interest expense	125,902	345,264
Non-cash interest expense	298,149	1,398,874
Amortization of debt discount	4,437,611	16,520,326
Loss on Note Receivable	0	99,000
Loss on Joint Venture	0	120,000
Accrued litigation settlement	(401,268)	(366,013)
Deemed interest expense on warrant liability	0	909,092
Change in fair value of derivatives and gain/loss on extinguishment of liabilities, net	7,928,578	(5,402,099)
Bad debt expense	246,116	77,524
Changes in operating assets and liabilities:
Accounts receivable	1,506,462	717,311
Inventories	813,735	(2,061,983)
Prepaid expenses and other current assets	497,325	644,828
Accounts payable	382,738	606,725
Accrued expenses	238,768	(889,272)
Warranty reserve	(34,834)	78,000
Net cash used in operating activities	(13,550,791)	(17,506,811)
Investing Activities:
Purchase of property, plant and equipment	(40,262)	(29,194)
Interest income on restricted cash	0	(49,446)
Patent activity costs	(152,076)	(246,337)
Net cash used in investing activities	(192,338)	(324,977)
Financing Activities:
Payment of debt financing costs	(40,000)	(416,250)
Repayment of debt	(211,648)	(199,256)
Proceeds from promissory note	300,000	0
Proceeds from convertible notes	2,000,000	2,000,000
Changes in restricted cash	0	9,250,000
Proceeds from Committed Equity Line	1,056,147	0
Proceeds from issuance of stock and warrants	10,405,000	4,500,000
Net cash provided by financing activities	13,509,499	15,134,494
Net change in cash and cash equivalents	(233,630)	(2,697,294)
Cash and cash equivalents at beginning of period	326,217	3,316,576
Cash and cash equivalents at end of period	92,587	619,282
Supplemental Cash Flow Information:
Cash paid for interest	267,666	347,138
Non-Cash Transactions:
Non-cash conversions of preferred stock and convertible notes to equity	$ 9,236,810	$ 14,221,926